H2 2012 | Aarkstore.com || Neuralgia – pipeline review, h2 2012

1. You can also request for sample page of above
mention reports on sample@aarkstore.com

2. Pages : 147
PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $
6000 |

3. Summary
Global Markets Direct’s, Neuralgia - Pipeline Review, H2 2012, provides an
overview of the indication’s therapeutic pipeline. This report provides
information on the therapeutic development for Neuralgia, complete with latest
updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Neuralgia.
Neuralgia - Pipeline Review, Half Year is built using data and information
sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

4. Scope
- A snapshot of the global therapeutic scenario for Neuralgia.
- A review of the Neuralgia products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Neuralgia.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.

5. Table of Contents :
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Neuralgia Overview 11
Therapeutics Development 12
An Overview of Pipeline Products for Neuralgia 12
Neuralgia Therapeutics under Development by Companies 14
Neuralgia Therapeutics under Investigation by Universities/Institutes 18
Late Stage Products 20
Comparative Analysis 20
Mid Clinical Stage Products 21
Comparative Analysis 21
Early Clinical Stage Products 22
Comparative Analysis 22
Discovery and Pre-Clinical Stage Products 23
Comparative Analysis 23
Neuralgia Therapeutics – Products under Development by Companies 24
Neuralgia Therapeutics – Products under Investigation by
Universities/Institutes 25…………………..

6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline
Review, H2 2012&PubId=&pagenum=1

7. Related Reports:
Hereditary Angioedema (HAE) – Pipeline Review, H2 2012
Dermatomycoses – Pipeline Review, H2 2012
Familial Adenomatous Polyposis Coli – Pipeline Review, H2 2012
Tinnitus – Pipeline Review, H2 2012
Premenstrual Syndrome – Pipeline Review, H2 2012
Wrinkles – Pipeline Review, H2 2012
Genital Warts (Condylomata Acuminata) – Pipeline Review, H2
2012
Fabry Disease – Pipeline Review, H2 2012
Thyroid Gland Disorders – Pipeline Review, H2 2012
Proteinuria – Pipeline Review, H2 2012
Viral Conjunctivitis – Pipeline Review, H2 2012
Mixed Dyslipidemia – Pipeline Review, H2 2012
Keratitis – Pipeline Review, H2 2012
Generalized Seizures – Pipeline Review, H2 2012
Cataract – Pipeline Review, H2 2012
Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review,
H2 2012
Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012

8. For More details about above & other
Reports plz contact :
Lavanya
Aarkstore.com
Contact: Marketing team Mob.No.918149852585
Email: enquiry@aarkstore.com ,
discount@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore